Jacob Pontoppidan Thyssen

Jacob Pontoppidan Thyssen

Professor, emeritus

Member of:

  • Dermatovenerology


  1. 2023
  2. Published

    The optimal biologic treatment target for hidradenitis suppurativa remains undiscovered

    Egeberg, Alexander & Thyssen, Jacob Pontoppidan, 2023, In: The Lancet. 401, 10378, p. 708-710 3 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  3. Published

    Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study

    Nielsen, M., Thein, D., Rasmussen, M. K., Bertelsen, T., Dam, T. N., Skov, Lone, Bryld, Lars Erik, Wu, J. J., Thomsen, Simon Francis, Thyssen, Jacob Pontoppidan & Egeberg, Alexander, 2023, In: Journal of the American Academy of Dermatology. 88, 6, p. 1378-1381 4 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  4. Published

    Treatment of chronic hand eczema with dupilumab-A retrospective follow-up study

    Olesen, C. M., Yüksel, Y. T., Zachariae, Claus, Lund, T. T., Agner, Tove, Petersen, Tonny Studsgaard & Thyssen, Jacob Pontoppidan, 2023, In: Journal of the European Academy of Dermatology and Venereology : JEADV. 37, 4, p. e557-e559

    Research output: Contribution to journalComment/debateResearchpeer-review

  5. Published

    Treatment with delgocitinib cream improves itch, pain and other signs and symptoms of chronic hand eczema: Results from the Hand Eczema Symptom Diary in a phase IIb randomized clinical trial

    Bauer, A., Thyssen, Jacob Pontoppidan, Buhl, T., Nielsen, T. S. S., Larsen, L. S., Østerskov, A. B. & Agner, Tove, 2023, In: Contact Dermatitis. 89, 1, p. 46-53 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Upadacitinib for moderate-to-severe atopic dermatitis: Stratified analysis from three randomized phase 3 trials by key baseline characteristics

    Thyssen, Jacob Pontoppidan, Thaçi, D., Bieber, T., Gooderham, M., de Bruin-Weller, M., Soong, W., Kabashima, K., Barbarot, S., Luna, P. C., Xu, J., Hu, X., Liu, Y., Raymundo, E. M., Calimlim, B. M., Nduaka, C., Gamelli, A. & Simpson, E. L., 2023, In: Journal of the European Academy of Dermatology and Venereology. 37, 9, p. 1871-1880 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Validity and reliability of the Rosacea Area and Severity Index: A novel scoring system for clinical assessment of rosacea severity

    Wienholtz, N. K. F., Thyssen, J. P., Christensen, C. E., Thomsen, S. F., Karmisholt, K. E., Jemec, G. B. E., Lomholt, H. B., Heidenheim, M., Simonsen, A. B., Sand, C., Vestergaard, C., Kaur-Knudsen, D., Ammitzbøll, E., Lørup, E., Danielsen, A. G., Strauss, G., Skov, L., Andersen, P. H., Hald, M., Idorn, L. W. & 3 others, dlt446, dlt446, Zachariae, Claus & Egeberg, Alexander, 2023, In: Journal of the European Academy of Dermatology and Venereology. 37, 3, p. 573-580 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. 2022
  9. Published

    Patient perspectives of atopic dermatitis: comparative analysis of terminology in social media and scientific literature, identified by a systematic literature review

    Silverberg, J. I., Feldman, S. R., Smith Begolka, W., Johnson, M. B., Stanojev, C., Dibonaventura, M., Rojo Cella, R., Valdez, H., Feeney, C. & Thyssen, Jacob Pontoppidan, 1 Nov 2022, In: Journal of the European Academy of Dermatology and Venereology. 36, 11, p. 1980-1990

    Research output: Contribution to journalReviewResearchpeer-review

  10. Published

    Sonelokimab Interleukin-17A and -F nanobody Treatment of moderate to severe psoriasis Treatment of hidradenitis suppurativa

    Yao, Y., Jorgensen, A. R., Nielsen, V. W., Egeberg, Alexander, Thyssen, Jacob Pontoppidan & Thomsen, Simon Francis, Aug 2022, In: Drugs of the Future. 47, 8, p. 567-573 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    High threshold efficacy responses in moderate-to-severe atopic dermatitis are associated with additional quality of life benefits: pooled analyses of abrocitinib monotherapy studies in adults and adolescents

    Stander, S., Bhatia, N., Gooderham, M. J., Silverberg, J., Thyssen, Jacob Pontoppidan, Biswas, P., DiBonaventura, M., Romero, W. & Farooqui, S. A., 6 May 2022, In: Journal of the European Academy of Dermatology and Venereology. 36, 8, p. 1308-1317 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Conjunctivitis in adult patients with moderate-to-severe atopic dermatitis: results from five tralokinumab clinical trials

    Wollenberg, A., Beck, L. A., de Bruin Weller, M., Simpson, E. L., Imafuku, S., Boguniewicz, M., Zachariae, R., Olsen, C. K. & Thyssen, Jacob Pontoppidan, Mar 2022, In: British Journal of Dermatology. 186, 3, p. 453-465 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1...4 5 6 7 8 9 10 11 ...55 Next

ID: 33972183